Netcapital (NCPL) Competitors $1.90 +0.08 (+4.40%) Closing price 03/14/2025 03:59 PM EasternExtended Trading$1.90 +0.00 (+0.21%) As of 03/14/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends NCPL vs. NRBO, BTCT, MCVT, GRYP, AIHS, GREE, MIGI, SLNH, CARV, and SAIHShould you be buying Netcapital stock or one of its competitors? The main competitors of Netcapital include NeuroBo Pharmaceuticals (NRBO), BTC Digital (BTCT), Mill City Ventures III (MCVT), Gryphon Digital Mining (GRYP), Senmiao Technology (AIHS), Greenidge Generation (GREE), Mawson Infrastructure Group (MIGI), Soluna (SLNH), Carver Bancorp (CARV), and SAIHEAT (SAIH). These companies are all part of the "banking" industry. Netcapital vs. NeuroBo Pharmaceuticals BTC Digital Mill City Ventures III Gryphon Digital Mining Senmiao Technology Greenidge Generation Mawson Infrastructure Group Soluna Carver Bancorp SAIHEAT NeuroBo Pharmaceuticals (NASDAQ:NRBO) and Netcapital (NASDAQ:NCPL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, community ranking, earnings, profitability and analyst recommendations. Which has more volatility & risk, NRBO or NCPL? NeuroBo Pharmaceuticals has a beta of -0.26, indicating that its stock price is 126% less volatile than the S&P 500. Comparatively, Netcapital has a beta of -0.48, indicating that its stock price is 148% less volatile than the S&P 500. Does the MarketBeat Community favor NRBO or NCPL? NeuroBo Pharmaceuticals received 27 more outperform votes than Netcapital when rated by MarketBeat users. CompanyUnderperformOutperformNeuroBo PharmaceuticalsOutperform Votes2775.00% Underperform Votes925.00% NetcapitalN/AN/A Do institutionals and insiders believe in NRBO or NCPL? 1.4% of NeuroBo Pharmaceuticals shares are owned by institutional investors. Comparatively, 30.7% of Netcapital shares are owned by institutional investors. 1.1% of NeuroBo Pharmaceuticals shares are owned by insiders. Comparatively, 6.8% of Netcapital shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has higher earnings and valuation, NRBO or NCPL? Netcapital has higher revenue and earnings than NeuroBo Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroBo PharmaceuticalsN/AN/A-$12.47MN/AN/ANetcapital$1.70M2.05-$4.99M-$31.92-0.06 Is NRBO or NCPL more profitable? NeuroBo Pharmaceuticals has a net margin of 0.00% compared to Netcapital's net margin of -562.71%. Netcapital's return on equity of -25.03% beat NeuroBo Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets NeuroBo PharmaceuticalsN/A -189.12% -122.31% Netcapital -562.71%-25.03%-22.67% Do analysts recommend NRBO or NCPL? NeuroBo Pharmaceuticals presently has a consensus target price of $10.00, suggesting a potential upside of 575.68%. Given NeuroBo Pharmaceuticals' stronger consensus rating and higher probable upside, equities research analysts plainly believe NeuroBo Pharmaceuticals is more favorable than Netcapital.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroBo Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Netcapital 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer NRBO or NCPL? In the previous week, Netcapital had 2 more articles in the media than NeuroBo Pharmaceuticals. MarketBeat recorded 2 mentions for Netcapital and 0 mentions for NeuroBo Pharmaceuticals. Netcapital's average media sentiment score of 0.94 beat NeuroBo Pharmaceuticals' score of 0.00 indicating that Netcapital is being referred to more favorably in the news media. Company Overall Sentiment NeuroBo Pharmaceuticals Neutral Netcapital Positive SummaryNetcapital beats NeuroBo Pharmaceuticals on 8 of the 14 factors compared between the two stocks. Remove Ads Get Netcapital News Delivered to You Automatically Sign up to receive the latest news and ratings for NCPL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NCPL vs. The Competition Export to ExcelMetricNetcapitalNondepository credit institutions IndustryBusiness SectorNASDAQ ExchangeMarket Cap$3.35M$7.45B$7.25B$8.12BDividend YieldN/A4.36%2.26%4.10%P/E Ratio-0.0616.0532.2019.07Price / Sales2.059.37143.8588.27Price / CashN/A42.1531.6134.64Price / Book0.022.114.814.29Net Income-$4.99M$530.52M$190.91M$247.56M7 Day Performance-2.06%-4.55%0.97%-0.84%1 Month Performance-21.81%-17.92%-9.09%-9.37%1 Year Performance-79.74%10.00%6.17%4.01% Netcapital Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NCPLNetcapital0.3867 of 5 stars$1.90+4.4%N/A-79.6%$3.35M$1.70M-0.06N/AUpcoming EarningsNews CoverageNRBONeuroBo PharmaceuticalsN/A$1.55-1.3%$10.00+545.2%-67.8%$13.36MN/A0.0010Gap UpBTCTBTC Digital1.1758 of 5 stars$3.87-13.0%N/A+36.5%$12.76M$8.48M0.0016Short Interest ↓News CoverageGap DownMCVTMill City Ventures III1.224 of 5 stars$1.81-3.9%N/A-26.1%$11.56M$2.39M-25.852Earnings ReportShort Interest ↑News CoverageGRYPGryphon Digital Mining1.2119 of 5 stars$0.19-18.2%N/A-86.1%$9.92M$7.69M0.00200Short Interest ↓AIHSSenmiao Technology0.2599 of 5 stars$0.88-0.6%N/A-12.1%$9.26M$5.88M-2.75150GREEGreenidge Generation3.546 of 5 stars$0.77-10.5%$4.00+418.8%-76.7%$8.60M$64.38M0.00680Gap DownMIGIMawson Infrastructure Group2.8027 of 5 stars$0.44-3.9%$2.00+351.5%-62.9%$8.29M$58.22M-0.1440Short Interest ↓Gap DownSLNHSoluna0.5252 of 5 stars$0.94-8.9%N/A-68.7%$7.86M$39.87M-0.0660Short Interest ↑News CoverageCARVCarver Bancorp0.5734 of 5 stars$1.51-2.7%N/A-12.7%$7.72M$24.59M-0.79110SAIHSAIHEATN/A$0.45-6.0%N/AN/A$6.52M$6.95M0.0037Stock SplitNews CoverageGap Up Remove Ads Related Companies and Tools Related Companies NeuroBo Pharmaceuticals Competitors BTC Digital Competitors Mill City Ventures III Competitors Gryphon Digital Mining Competitors Senmiao Technology Competitors Greenidge Generation Competitors Mawson Infrastructure Group Competitors Soluna Competitors Carver Bancorp Competitors SAIHEAT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NCPL) was last updated on 3/16/2025 by MarketBeat.com Staff From Our PartnersElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Netcapital Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Netcapital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NCPL Stock Alerts